These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 19081257
1. Design, synthesis, and binding affinities of potential positron emission tomography (PET) ligands with optimal lipophilicity for brain imaging of the dopamine D3 receptor. Part II. Leopoldo M, Lacivita E, De Giorgio P, Contino M, Berardi F, Perrone R. Bioorg Med Chem; 2009 Jan 15; 17(2):758-66. PubMed ID: 19081257 [Abstract] [Full Text] [Related]
2. Design, synthesis, and binding affinities of potential positron emission tomography (PET) ligands for visualization of brain dopamine D3 receptors. Leopoldo M, Lacivita E, De Giorgio P, Colabufo NA, Niso M, Berardi F, Perrone R. J Med Chem; 2006 Jan 12; 49(1):358-65. PubMed ID: 16392820 [Abstract] [Full Text] [Related]
3. Structure-selectivity investigations of D2-like receptor ligands by CoMFA and CoMSIA guiding the discovery of D3 selective PET radioligands. Salama I, Hocke C, Utz W, Prante O, Boeckler F, Hübner H, Kuwert T, Gmeiner P. J Med Chem; 2007 Feb 08; 50(3):489-500. PubMed ID: 17266201 [Abstract] [Full Text] [Related]
4. 18F-Labeled FAUC 346 and BP 897 derivatives as subtype-selective potential PET radioligands for the dopamine D3 receptor. Hocke C, Prante O, Salama I, Hübner H, Löber S, Kuwert T, Gmeiner P. ChemMedChem; 2008 May 08; 3(5):788-93. PubMed ID: 18306190 [Abstract] [Full Text] [Related]
5. Synthesis and radiolabeling of N-[4-[4-(2-[11C]methoxyphenyl)piperazin-1-yl]butyl]benzo[b]thiophene-2-carboxamide -- a potential radiotracer for D3 receptor imaging with PET. Kuhnast B, Valette H, Besret L, Demphel S, Coulon C, Ottaviani M, Guillermier M, Bottlaender M, Dollé F. Nucl Med Biol; 2006 Aug 08; 33(6):785-95. PubMed ID: 16934697 [Abstract] [Full Text] [Related]
6. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor. Grundt P, Carlson EE, Cao J, Bennett CJ, McElveen E, Taylor M, Luedtke RR, Newman AH. J Med Chem; 2005 Feb 10; 48(3):839-48. PubMed ID: 15689168 [Abstract] [Full Text] [Related]
13. 11C-labeling of n-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl]arylcarboxamide derivatives and evaluation as potential radioligands for PET imaging of dopamine D3 receptors. Turolla EA, Matarrese M, Belloli S, Moresco RM, Simonelli P, Todde S, Fazio F, Magni F, Kienle MG, Leopoldo M, Berardi F, Colabufo NA, Lacivita E, Perrone R. J Med Chem; 2005 Nov 03; 48(22):7018-23. PubMed ID: 16250661 [Abstract] [Full Text] [Related]
14. Synthesis and binding profile of constrained analogues of N-[4-(4-arylpiperazin-1-yl)butyl]-3-methoxybenzamides, a class of potent dopamine D3 receptor ligands. Leopoldo M, Lacivita E, Colabufo NA, Berardi F, Perrone R. J Pharm Pharmacol; 2006 Feb 03; 58(2):209-18. PubMed ID: 16451749 [Abstract] [Full Text] [Related]
15. Synthesis and evaluation of amides surrogates of dopamine D3 receptor ligands. Jean M, Renault J, Levoin N, Danvy D, Calmels T, Berrebi-Bertrand I, Robert P, Schwartz JC, Lecomte JM, Uriac P, Capet M. Bioorg Med Chem Lett; 2010 Sep 15; 20(18):5376-9. PubMed ID: 20708933 [Abstract] [Full Text] [Related]
16. Synthesis, binding affinity and SAR of new benzolactam derivatives as dopamine D3 receptor ligands. Ortega R, Raviña E, Masaguer CF, Areias F, Brea J, Loza MI, López L, Selent J, Pastor M, Sanz F. Bioorg Med Chem Lett; 2009 Mar 15; 19(6):1773-8. PubMed ID: 19217777 [Abstract] [Full Text] [Related]
17. Parallel synthesis and dopamine D3/D2 receptor screening of novel {4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl}carboxamides. Heidler P, Zohrabi-Kalantari V, Calmels T, Capet M, Berrebi-Bertrand I, Schwartz JC, Stark H, Link A. Bioorg Med Chem; 2005 Mar 15; 13(6):2009-14. PubMed ID: 15727854 [Abstract] [Full Text] [Related]